Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes

Journal of Medicinal Chemistry

Volumn 46, Issue 5, 2003, Pages 734-746

  Nöteberg, Daniel ^a   Hamelink, Elizabeth ^b   Hultén, Johan ^a   Wahlgren, Mats ^c   Vrang, Lotta ^b   Samuelsson, Bertil ^b   Hallberg, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDIVIR AB   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; PLASMEPSIN I; PLASMEPSIN I INHIBITOR; PLASMEPSIN II; PLASMEPSIN II INHIBITOR; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; HUMAN CELL; MALARIA; PARASITE SURVIVAL; PLASMODIUM FALCIPARUM;

ANIMALS; ASPARTIC ENDOPEPTIDASES; CELLS, CULTURED; ERYTHROCYTES; HUMANS; PLASMODIUM FALCIPARUM; PROTEASE INHIBITORS;

EID: 0037468420     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm020951i     Document Type: Article

References (24)

1. Breman, J. G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. Trop. Med. Hyg. 2001, 64, 1-11.
2. Olliaro, P.; Cattani, J.; Wirth, D. Malaria, the submerged disease. JAMA 1996, 275, 230-233.
3. Francis, S. E.; Sullivan, D. J., Jr.; Goldberg, D. E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 1997, 51, 97-123.
4. Rosenthal, P. J.; Meshnick, S. R. Hemoglobin catabolism and iron utilization by malaria parasites. Mol. Biochem. Parasitol. 1996, 83, 131-139.
5. Silva, A. M.; Lee, A. Y.; Gulnik, S. V.; Majer, P.; Collins, J.; Bhat, T. N.; Collins, P. J.; Cachau, R. E.; Luker, K. E.; Gluzman, I. Y.; Francis, S. E.; Oksman, A.; Goldberg, D. E.; Erickson, J. W. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 10034-10039.
6. Carroll, C. D.; Patel, H.; Johnson, T. O.; Guo, T.; Orlowski, M.; He, Z. M.; Cavallaro, C. L.; Guo, J.; Oksman, A.; Gluzman, I. Y.; Connelly, J.; Chelsky, D.; Goldberg, D. E.; Dolle, R. E. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. Bioorg. Med. Chem. Lett. 1998, 8, 2315-2320.
7. Carroll, C. D.; Johnson, T. O.; Tao, S.; Lauri, G.; Orlowski, M.; Gluzman, I. Y.; Goldberg, D. E.; Dolle, R. E. Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D. Bioorg. Med. Chem. Lett. 1998, 8, 3203-3206.
8. Haque, T. S.; Skillman, A. G.; Lee, C. E.; Habashita, H.; Gluzman, I. Y.; Ewing, T. J. A.; Goldberg, D. E.; Kuntz, I. D.; Ellman, J. A. Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II. J. Med. Chem. 1999, 42, 1428-1440.
9. Romeo, S.; Rich, D. H. Stereoselective synthesis of protected aminoalkyl epoxides. Tetrahedron Lett. 1994, 35, 4939-4942.
10. Akerblom, E. B.; Nygren, A. S.; Agback, K. H. Six new photolabile linkers for solid-phase synthesis. 1. Methods of preparation. Mol. Diversity 1998, 3, 137-148.
11. Akerblom, E. B. Six new photolabile linkers for solid-phase synthesis. 2. Coupling of various building blocks and photolytic cleavage. Mol. Diversity 1999, 4, 53-69.
12. Tong, J. H.; Petitclerc, C.; D'Iorio, A.; Benoiton, N. I. Resolution of ring-substituted phenylalanines by the action of alpha-chymotrypsin on their ethyl esters. Can. J. Biochem. 1971, 49, 877-881.
13. Larhed, M.; Lindeberg, G.; Hallberg, A. Rapid microwave-assisted Suzuki coupling on solid-phase. Tetrahedron Lett. 1996, 37, 8219-8222.
14. Alterman, M.; Andersson, H. O.; Garg, N.; Ahlsen, G.; Loevgren, S.; Classon, B.; Danielson, U. H.; Kvarnstroem, I.; Vrang, L.; Unge, T.; Samuelsson, B.; Hallberg, A. Design and fast synthesis of C-terminal duplicated potent C2-symmetric P1/P1′-modified HIV-1 protease inhibitors. J. Med. Chem. 1999, 42, 3835-3844.
15. Lehmannn, F. Ueber die condensation von benzaldehydcyanohydrin mit urethan. Chem. Ber. 1901, 34, 370-377.
16. Avendano Lopez, C.; Gonzalez Trigo, G. The chemistry of hydantoins. Adv. Heterocycl. Chem. 1985, 38, 177-228.
17. Northrop, D. B. Follow the protons: A low-barrier hydrogen bond unifies the mechanisms of the aspartic proteases. Acc. Chem. Res. 2001, 34, 790-797.
18. Tucker, T. J.; Lumma, W. C., Jr.; Payne, L. S.; Wai, J. M.; De Solms, S. J.; Giuliani, E. A.; Darke, P. L.; Heimbach, J. C.; Zugay, J. A.; Schleif, W. A.; Quintero, J. C.; Emini, E. A.; Huff, J. R.; Anderson, P. S. A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity. J. Med. Chem. 1992, 35, 2525-2533.
19. Wyatt David, M.; Berry, C. Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum. FEBS Lett. 2002, 513, 159-162.
20. Banerjee, R.; Liu, J.; Beatty, W.; Pelosof, L.; Klemba, M.; Goldberg, D. E. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an activesite histidine. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 990-995.
21. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
22. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis; Copeland, R. A., Ed.; 1996; p 300.
23. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
24. Desjardins, R. E.; Canfield, C. J.; Haynes, J. D.; Chulay, J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 1979, 16, 710-718.